New agents and regimens for diffuse large B cell lymphoma

Liang Wang(Zhujiang Hospital), Ken H. Young(The University of Texas MD Anderson Cancer Center)
Journal of Hematology & Oncology
December 1, 2020
10.1186/s13045-020-01011-z
Cited by 173

Related Papers

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
|Blood|2017|429
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
|Modern Pathology|2019|55
Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia
|Cell Communication and Signaling|2019|24